Patent · US Active

Benzylidene-indolinone compounds and their medical use

US8877946B2 · kind B2 · utility

1Cited by
1References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 1, 2012
Grant dateNov 4, 2014
Priority date—
Expiry dateAug 1, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of general formula I:whereinR1a, R1b, R2, R3a, R3b and X are as defined herein are tyrosine kinase inhibitors and are useful for the treatment of various diseases and conditions, for example cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.